Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Nishimura

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Stem Cells and Development|December 1, 2020
Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem CellsKazuto Kimura, Masaya Tsukamoto, Miyuu Tanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2010
[Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas]Manabu Shiozawa, Ken Nishimura, Tetsuo Nonaka, et al.
Virology|July 13, 2004
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRESKen Nishimura, Keiji Ueda, Edhi Guwanan, et al.
In Vitro Cellular & Developmental Biology. Animal|November 13, 2015
Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free cultureSachiko Yamasaki, Atsuko Hamada, Eri Akagi, et al.
Stem Cells Translational Medicine|October 31, 2014
Advanced feeder-free generation of induced pluripotent stem cells directly from blood cellsRas Trokovic, Jere Weltner, Ken Nishimura, et al.
ACS Chemical Biology|January 25, 2024
Ubiquitin-Derived Fragment as a Peptide Linker for the Efficient Cleavage of a Target Protein from a DegronYuki Utsugi, Ken Nishimura, Satoshi Yamanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2016
A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancerNorisuke Nakayama, Kenji Ishido, Keisho Chin, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 10, 2021
[A case of Listeria meningitis with active ulcerative colitis and a review of literature in the Japanese cases]Kohei Asaeda, Yusuke Okuyama, Yoshikazu Nakatsugawa, et al.
International Journal of Cancer|July 10, 2009
Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancerWasaburo Koizumi, Satoshi Tanabe, Mizutomo Azuma, et al.
Journal of Biological Engineering|January 16, 2024
An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectorsTakumi Kishimoto, Ken Nishimura, Kana Morishita, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Stem Cells and Development|December 1, 2020
Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem CellsKazuto Kimura, Masaya Tsukamoto, Miyuu Tanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 17, 2010
[Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas]Manabu Shiozawa, Ken Nishimura, Tetsuo Nonaka, et al.
Virology|July 13, 2004
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRESKen Nishimura, Keiji Ueda, Edhi Guwanan, et al.
In Vitro Cellular & Developmental Biology. Animal|November 13, 2015
Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free cultureSachiko Yamasaki, Atsuko Hamada, Eri Akagi, et al.
Stem Cells Translational Medicine|October 31, 2014
Advanced feeder-free generation of induced pluripotent stem cells directly from blood cellsRas Trokovic, Jere Weltner, Ken Nishimura, et al.
ACS Chemical Biology|January 25, 2024
Ubiquitin-Derived Fragment as a Peptide Linker for the Efficient Cleavage of a Target Protein from a DegronYuki Utsugi, Ken Nishimura, Satoshi Yamanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2016
A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancerNorisuke Nakayama, Kenji Ishido, Keisho Chin, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 10, 2021
[A case of Listeria meningitis with active ulcerative colitis and a review of literature in the Japanese cases]Kohei Asaeda, Yusuke Okuyama, Yoshikazu Nakatsugawa, et al.
International Journal of Cancer|July 10, 2009
Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancerWasaburo Koizumi, Satoshi Tanabe, Mizutomo Azuma, et al.
Journal of Biological Engineering|January 16, 2024
An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectorsTakumi Kishimoto, Ken Nishimura, Kana Morishita, et al.
Pageof 10